CompletedNot Applicable

Identification and Treatment of Diabetes In Solid Organ Transplant Recipients

United States65 participantsStarted 2016-07-07

Plain-language summary

The purpose of this study is to determine the influence of post-transplant diabetes on medical and psychosocial outcomes in individuals who receive solid-organ transplant prior to 18 years of age and their families.

Who can participate

Age range1 Year – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of Children's Healthcare of Atlanta who have received a kidney, liver, or heart transplant Exclusion Criteria: * Received a transplant after 18 years of age * Cognitively unable to participant as determined by the study team psychologist * Not receiving a solid organ transplant for kidney, liver, or heart * Declines participation invitation

What they're measuring

Change in the Pediatric Quality of Life Inventory Transplant Module (PedsQL)

Timeframe: Baseline, interval, and end of participation (Up to 18 years of age)

Trial details

NCT IDNCT02605200

SponsorEmory University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11-14

View on ClinicalTrials.gov More Complications of Transplanted Organs and Tissue trials